Alvotech and Dr. Reddy's gets FDA nod for Biologic License Application for AVT03
Source: SeekingAlpha
2025-03-18 10:06:06 ET
More on Alvotech, Amgen, etc.
- Amgen: Riding The MariTide Of Monthly Weight Loss
- Amgen Inc. (AMGN) 45th Annual TD Cowen Health Care Conference (Transcript)
- Amgen Stock: Why I Still Rate It A 'Buy'
- Regeneron falls after appeals court ruling in Eylea case (update)
- FDA commissioner nominee Makary advances to full Senate vote
Read the full article on Seeking Alpha
For further details see:
Alvotech and Dr. Reddy’s gets FDA nod for Biologic License Application for AVT03
Alvotech
NASDAQ: ALVO
ALVO Trading
-6.23% G/L:
$3.01 Last:
679,105 Volume:
$3.23 Open:
ALVO Latest News
May 11, 2026 04:30:00 am
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
ALVO Stock Data
$1,569,389,520
107,654,085
N/A
30
N/A
Pharmaceuticals
Healthcare
LU
Luxembourg
